145 related articles for article (PubMed ID: 17846355)
1. Comparison of methods to predict visual field progression in glaucoma.
Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
[TBL] [Abstract][Full Text] [Related]
2. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.
Nouri-Mahdavi K; Caprioli J; Coleman AL; Hoffman D; Gaasterland D
Arch Ophthalmol; 2005 Feb; 123(2):193-9. PubMed ID: 15710815
[TBL] [Abstract][Full Text] [Related]
3. Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).
O'Leary N; Chauhan BC; Artes PH
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6776-84. PubMed ID: 22952123
[TBL] [Abstract][Full Text] [Related]
4. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
[TBL] [Abstract][Full Text] [Related]
6. Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis.
Nassiri N; Moghimi S; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1208-13. PubMed ID: 23329667
[TBL] [Abstract][Full Text] [Related]
7. Pointwise rates of visual field progression cluster according to retinal nerve fiber layer bundles.
Nouri-Mahdavi K; Mock D; Hosseini H; Bitrian E; Yu F; Afifi A; Coleman AL; Caprioli J
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2390-4. PubMed ID: 22427560
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
9. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
[TBL] [Abstract][Full Text] [Related]
10. Pointwise linear regression analysis for detection of visual field progression with absolute versus corrected threshold sensitivities.
Manassakorn A; Nouri-Mahdavi K; Koucheki B; Law SK; Caprioli J
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2896-903. PubMed ID: 16799031
[TBL] [Abstract][Full Text] [Related]
11. Optic disc progression and rates of visual field change in treated glaucoma.
De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
[TBL] [Abstract][Full Text] [Related]
12. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.
Kim J; Dally LG; Ederer F; Gaasterland DE; VanVeldhuisen PC; Blackwell B; Sullivan EK; Prum B; Shafranov G; Beck A; Spaeth GL;
Ophthalmology; 2004 Nov; 111(11):2109-16. PubMed ID: 15522379
[TBL] [Abstract][Full Text] [Related]
13. Examination of the performance of different pointwise linear regression progression criteria to detect glaucomatous visual field change.
De Moraes CG; Liebmann CA; Susanna R; Ritch R; Liebmann JM
Clin Exp Ophthalmol; 2012; 40(4):e190-6. PubMed ID: 21902781
[TBL] [Abstract][Full Text] [Related]
14. A new index to monitor central visual field progression in glaucoma.
de Moraes CG; Furlanetto RL; Ritch R; Liebmann JM
Ophthalmology; 2014 Aug; 121(8):1531-8. PubMed ID: 24726202
[TBL] [Abstract][Full Text] [Related]
15. Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression.
de Moraes CG; Song C; Liebmann JM; Simonson JL; Furlanetto RL; Ritch R
Ophthalmology; 2014 Mar; 121(3):741-9. PubMed ID: 24290806
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for visual field progression in treated glaucoma.
De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
[TBL] [Abstract][Full Text] [Related]
17. Influence of visual field testing frequency on detection of glaucoma progression with trend analyses.
Nouri-Mahdavi K; Zarei R; Caprioli J
Arch Ophthalmol; 2011 Dec; 129(12):1521-7. PubMed ID: 21825177
[TBL] [Abstract][Full Text] [Related]
18. Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma.
Salazar D; Morales E; Rabiolo A; Capistrano V; Lin M; Afifi AA; Yu F; Nouri-Mahdavi K; Caprioli J
JAMA Ophthalmol; 2020 May; 138(5):536-543. PubMed ID: 32239185
[TBL] [Abstract][Full Text] [Related]
19. Monitoring glaucomatous progression using a novel Heidelberg Retina Tomograph event analysis.
Fayers T; Strouthidis NG; Garway-Heath DF
Ophthalmology; 2007 Nov; 114(11):1973-80. PubMed ID: 17662455
[TBL] [Abstract][Full Text] [Related]
20. Prediction of glaucomatous visual field loss by extrapolation of linear trends.
Bengtsson B; Patella VM; Heijl A
Arch Ophthalmol; 2009 Dec; 127(12):1610-5. PubMed ID: 20008716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
